Nifedipine and Atrioventricular block second degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block second degree is reported as a side effect among people who take Nifedipine (nifedipine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Spironolactone, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Nifedipine. It is created by eHealthMe based on reports of 52,610 people who have side effects when taking Nifedipine from the FDA, and is updated regularly.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 377 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.

On Jul, 13, 2026

52,610 people reported to have side effects when taking Nifedipine.
Among them, 39 people (0.07%) have Atrioventricular block second degree.

Could Nifedipine cause Atrioventricular block second degree?

Among these 39 people:

How long have people been on Nifedipine when they have Atrioventricular block second degree? *

What is the gender of people who have Atrioventricular block second degree when taking Nifedipine? *

female: 48.57 %
male: 51.43 %

What is the age of people who have Atrioventricular block second degree when taking Nifedipine? *

What are other drugs people take besides Nifedipine? *

What are other side effects people have besides Atrioventricular block second degree? *

Atrioventricular Block Complete (heart block complete): 17 people, 43.59%
Cardiac Arrest: 10 people, 25.64%
Consciousness - Decreased: 6 people, 15.38%
Ventricular Extrasystoles (premature cardiac contraction): 5 people, 12.82%
Nausea (feeling of having an urge to vomit): 5 people, 12.82%
Overdose: 5 people, 12.82%
Bradycardia (abnormally slow heart action): 5 people, 12.82%
Nausea And Vomiting: 4 people, 10.26%
Blood Creatinine Increased: 4 people, 10.26%
Hypotension (abnormally low blood pressure): 4 people, 10.26%

What are the existing conditions these people have? *

Anaemia (lack of blood): 3 people, 7.69%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 7.69%
High Blood Cholesterol: 2 people, 5.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.13%
Constipation: 2 people, 5.13%
Diabetes: 2 people, 5.13%
Herpes Zoster: 2 people, 5.13%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 5.13%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 5.13%
Pleural Effusion (water on the lungs): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Nifedipine and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nifedipine:

Nifedipine (53,459 reports)

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (377 drugs)

Browse all the conditions that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (818 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Nifedipine) and Nifedipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.